Back
uniQure NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Sell
18
QURE
uniQure NV
Last Price:
6.02
Seasonality Move:
5.58%
Buy
55
PRQR
ProQR Therapeutics NV
Last Price:
3.68
Seasonality Move:
8.38%
Sell
18
uniQure NV (QURE)
is a Sell
Is uniQure NV a Buy, Sell or Hold?
- The current uniQure NV [QURE] share price is $6.02. The Score for QURE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- QURE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
55
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $3.67. The Score for PRQR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QURE Stock Price Chart
What is uniQure NV's stock price today?
-
The uniQure NV share price today is $6.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QURE is experiencing slight buying pressure.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $3.67
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRQR is experiencing buying pressure, which is a positive indicator for future bullish movement.
QURE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 46.86 | Sell |
| Chaikin Money Flow: | 11183 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.77 - 6.99) | Sell |
| Bollinger Bands (100): | (5.35 - 7.59) | Sell |
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 55.56 | Buy |
| Chaikin Money Flow: | 260323 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.47 - 3.83) | Buy |
| Bollinger Bands (100): | (1.59 - 3.27) | Buy |
QURE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.92 | Buy |
| 20-day SMA: | 6.35 | Sell |
| 50-day SMA: | 5.95 | Buy |
| 200-day SMA: | 5.75 | Buy |
| 8-day EMA: | 6.05 | Sell |
| 20-day EMA: | 6.2 | Sell |
| 50-day EMA: | 6.15 | Sell |
| 200-day EMA: | 6.46 | Sell |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.6 | Buy |
| 20-day SMA: | 3.7 | Sell |
| 50-day SMA: | 2.95 | Buy |
| 200-day SMA: | 2.21 | Buy |
| 8-day EMA: | 3.62 | Buy |
| 20-day EMA: | 3.58 | Buy |
| 50-day EMA: | 3.14 | Buy |
| 200-day EMA: | 2.36 | Buy |
uniQure NV Earnings Growth & QURE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.34 per share, and an increase next year of $0.99 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.07 per share.
uniQure NV Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProQR Therapeutics NV Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||